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Genetic Determinants of Telomere 
Length in African American Youth
Andrew M. Zeiger1,2, Marquitta J. White1, Celeste Eng1, Sam S. Oh  1, Jonathan Witonsky1,3, 
Pagé C. Goddard1, Maria G. Contreras1,4,5, Jennifer R. Elhawary1, Donglei Hu1, Angel C. Y. Mak  1, 
Eunice Y. Lee1, Kevin L. Keys1, Lesly-Anne Samedy1,6, Oona Risse-Adams1,7, Joaquín Magaña1, 
Scott Huntsman1, Sandra Salazar1, Adam Davis8, Kelley Meade8, Emerita Brigino-Buenaventura9, 
Michael A. LeNoir10, Harold J. Farber11, Kirsten Bibbins-Domingo1, Luisa N. Borrell  12 & 
Esteban G. Burchard1,6
Telomere length (TL) is associated with numerous disease states and is affected by genetic and 
environmental factors. However, TL has been mostly studied in adult populations of European or Asian 
ancestry. These studies have identified 34 TL-associated genetic variants recently used as genetic 
proxies for TL. The generalizability of these associations to pediatric populations and racially diverse 
populations, specifically of African ancestry, remains unclear. Furthermore, six novel variants associated 
with TL in a population of European children have been identified but not validated. We measured TL 
from whole blood samples of 492 healthy African American youth (children and adolescents between 8 
and 20 years old) and performed the first genome-wide association study of TL in this population. We 
were unable to replicate neither the 34 reported genetic associations found in adults nor the six genetic 
associations found in European children. However, we discovered a novel genome-wide significant 
association between TL and rs1483898 on chromosome 14. Our results underscore the importance of 
examining genetic associations with TL in diverse pediatric populations such as African Americans.
Telomeres are DNA-protein structures composed of tandem hexamer repeat sequences (TTAGGGn) that cap 
the ends of each chromosome1. Telomeres play a vital role in maintaining DNA stability and integrity, and are 
therefore, critical for preserving genomic information2,3. With each mitotic division, a portion of telomeric DNA 
is lost. The cell enters senescence upon reaching a critical telomere length (TL) threshold4. TL has thus become 
an important biomarker of aging and overall health5–8. A complex interaction between genetic9 and non-genetic 
factors10 affects TL. While heritability estimates of TL range from 36% to 82%11, much is still unknown about 
genetic factors leading to variation in TL12,13.
Although epidemiological research in pediatric populations has linked TL to early life adversity14 and envi-
ronmental exposures15,16, few studies have focused on the genetic determinants of TL in pediatric populations. In 
contrast, several genetic studies of TL in European and Asian adults have identified and replicated 34 genetic vari-
ants associated with TL17–26. Over 30 studies have used these variants as genetic proxies for TL through Mendelian 
randomization approaches to address reverse causation when examining association between TL and disease in 
diseased patients17,27,28. However, recent studies in Chinese newborns and European children have failed to rep-
licate these variants, suggesting that they are not generalizable across age groups29,30. One study, by Stathopoulou 
et al., reported six novel genetic variants associated with TL in European children (age 4–18 years) not previously 
discovered in adult telomere studies30. Replication of these six genetic variants has not yet been attempted. Given 
1Department of Medicine, University of California, San Francisco, CA, USA. 2Department of Biology, University 
of Washington, Seattle, WA, USA. 3Department of Pediatrics, University of California, San Francisco, CA, USA. 
4SF BUILD, San Francisco State University, San Francisco, CA, USA. 5MARC, San Francisco State University, San 
Francisco, CA, USA. 6Department of Bioengineering and Therapeutic Sciences, University of California, San 
Francisco, CA, USA. 7Lowell Science Research Program, Lowell High School, San Francisco, CA, USA. 8Children’s 
Hospital and Research Center Oakland, Oakland, CA, USA. 9Department of Allergy and Immunology, Kaiser 
Permanente–Vallejo Medical Center, Vallejo, CA, USA. 10Bay Area Pediatrics, Oakland, CA, USA. 11Department of 
Pediatrics, Section of Pulmonology, Baylor College of Medicine and Texas Children’s Hospital, Houston, TX, USA. 
12Department of Epidemiology & Biostatistics, Graduate School of Public Health & Health Policy, City University of 
New York, New York, NY, USA. Andrew M. Zeiger and Marquitta J. White contributed equally. Correspondence and 
requests for materials should be addressed to M.J.W. (email: marquitta.white@ucsf.edu)
Received: 15 May 2018
Accepted: 6 August 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2SCIENTIFIC REPORTs |  (2018) 8:13265  | DOI:10.1038/s41598-018-31238-3
that adult TL appears determined prior to adulthood31, further research in diverse pediatric populations is neces-
sary to validate the existence of genetic effects on TL early in life.
Previous genetic studies of TL have been done almost exclusively in populations of European ancestry32, 
yet there is evidence that TL varies by race/ethnicity32–34. African Americans have been shown to have longer 
telomeres throughout life34–36 and a greater rate of telomere attrition than populations of European ancestry37. 
Population-specific differences in genetic variants have previously been shown across the genome38. Thus, it is 
possible that population-specific variation of genetic factors contributing to TL influences the difference in TL 
observed between populations of African and European ancestries33.
To further understand the relationship between genetic variants and TL, we performed the first large-scale 
genetic study of TL in African American children and adolescents (n = 492) from the Study of African Americans, 
Asthma, Genes and Environments (SAGE). Herein, we analyze genome-wide genetic data to attempt valida-
tion of previously reported genetic associations with TL and identify genetic variants influencing TL in African 
American children and adolescents.
Results
Study Population. Demographic information for the study population (n = 492) is presented in Table 1. The 
age of participants ranged from 8 to 20 with a median age of 15.8 (IQR = 12.4, 18.3; Table 1). Median African ances-
try was 0.81 (IQR = 0.74, 0.85; Table 1); additionally, we observed a subtle, but positive, correlation between African 
Ancestry and TL (β = 0.333, P = 0.022, Supplementary Fig. S1 and Supplementary Table S1). While individuals with 
public health insurance had significantly longer TL than individuals with private health insurance (P = 1.84 × 10−4), 
there was no significant association of age or maternal education with TL (Supplementary Table S1).
Evaluation of Previous Variants. We evaluated 40 variants, 34 from adult studies (Table 2) and six from a 
pediatric study (Table 3), for an association with log-transformed TL. None of the variants from either the adult or 
pediatric studies were significantly associated with TL in our study population (P > 0.05). To determine whether 
the combined effect of the six previously discovered pediatric variants was associated with TL in our study popula-
tion, we calculated a weighted genetic prediction score (GPS) by aggregating the allele associated with longer TL in 
European children weighted by the published β-coefficient30. There was no significant association between the GPS 
and TL in our study population of African American children and adolescents (β = 0.377, P = 0.150, Fig. 1).
Discovery Genome-Wide Association Study. We performed a discovery GWAS to identify significant 
and suggestive associations between common genetic variants and TL in our study population. We identified a 
novel association between rs1483898 and TL that reached genome-wide significance (P = 7.86 × 10−8, Fig. 2). 
Rs1483898 is an intergenic single nucleotide polymorphism (SNP) located proximal to the LRFN5 gene on chro-
mosome 14. An increase in copies of the rs1483898 A allele was significantly associated with longer TL (β = 0.148, 
P = 7.86 × 10−8, Fig. 3) and rs1483898 had a minor allele frequency (MAF) of 0.236 in our study population. We 
also discovered 41 suggestive associations between common variants and TL (P < 2.32 × 10−6, Supplementary 
Table S2). Of particular note were rs9675924 (β = −0.171, P = 2.27 × 10−6, Supplementary Table S2) located in 
CABLES1 and rs4305653 (β = 0.167, P = 1.81 × 10−6, Supplementary Table S2) located in TTC37. These genes 
have been previously associated with telomere biology39,40.
Discussion
In this study, we contribute to the nascent body of research on genetic determinants of TL by assessing the gen-
eralizability of genetic markers of TL to African American children and adolescents. Our results are consistent 
with recent studies in pediatric populations29,30 that did not replicate variants associated with TL in adults17–26, 
suggesting that these variants may not play a significant role in the regulation of TL during the first two decades 
of growth and development. However, we were also unable to replicate genetic variants associated with TL in a 
population of European children30, highlighting potential population-specific effects of genetic associations with 
TL. Lastly, we identified a genome-wide significant variant, rs1483898, and 41 suggestively associated variants 
within genes relevant to telomere biology in a GWAS for TL in African American children and adolescents.
Variable N (%)
Median age [IQR] 15.8 [12.4, 18.3]a
Sex (% Female) 270 (55.3)
Median relative telomere length [IQR] (T/S ratio) 0.0393 [0.0319, 0.0506]a
Median African ancestry [IQR] 0.81 [0.74, 0.85]a
Maternal education attainment
   ≤High school 185 (37.6)
   >High school 307 (62.4)
Insurance
   Public 260 (52.8)
   Private 232 (47.2)
Table 1. Demographic characteristics of healthy African American children and adolescents (n = 492) in 
SAGE: San Francisco Bay Area, 2006–2015. aMedian [IQR] presented for selected variable.
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Genetic determinants of TL are critical to understanding inter-individual variation in TL. However, most 
studies of TL have been performed in adults, after the developmental time window when age-dependent tel-
omere shortening may have already occurred32. Studies conducted among adults have identified and replicated 
Reference SNP
Chr. Position
(GRCh38.p7) Associated Gene EAa
Previously Reported SAGE (n = 492)
EAFb ßc P EAFb ßc P
Codd et al.17
rs11125529 2:54475866 ACYP2 C 0.86 −0.056 4.48E-8 0.82 −0.0525 0.090
rs2736100 5:1286516 TERT A 0.51 −0.078 4.38E-19 0.50 −0.0341 0.145
rs7675998 4:164007820 NAF1 A 0.28 −0.074 4.35E-16 0.28 −0.0318 0.275
rs8105767 19:22215441 ZNF208 A 0.71 −0.048 1.11E-9 0.55 0.0086 0.721
rs10936599 3:169492101 TERC T 0.25 −0.097 2.54E-31 0.08 0.0119 0.789
rs9420907 10:105676465 OBFC1 A 0.87 −0.069 6.90E-11 0.51 −0.00484 0.847
rs755017 20:62421622 RTEL1 A 0.87 −0.062 6.71E-9 0.73 −0.00021 0.994
Pooley et al.18
rs6772228 3:58376019 PXK A 0.05 0.120 4.67E-17 0.01 −0.2023 0.083
rs10936601 3:169528449 TERC C 0.27 4.45E-4 4.00E-15 0.48 −0.00066 0.978
Mangino et al.19
rs3027234 17:8136092 CTC1 T 0.23 −0.057 2.29E-8 0.07 0.0223 0.644
rs1317082 3:169497585 TERC G 0.29 0.068 1.00E-8 0.08 0.0119 0.789
rs412658 19:22359440 ZNF676 T 0.35 0.056 1.00E-8 0.57 −0.0067 0.791
rs9419958 10:105675946 OBFC1 T 0.14 0.083 9.00E-11 0.50 0.00484 0.847
Mangino et al.20 rs2162440 18:35214006 BRUNOL4, PIKC3C G NRe −1.06 3.00E-6 0.58 0.0319 0.212
Prescott et al.21 rs12696304 3:169481271 TERC G 0.27 −0.03 2.00E-14 0.53 −0.0021 0.929
Levy et al.22
rs4452212 2:137015991 CXCR4 A 0.65 −0.08 2.00E-6 0.14 −0.0465 0.180
rs2736428 6:31843924 SLC44A4 T 0.29 0.08 3.00E-6 0.10 0.0499 0.227
rs1975174 19:22515251 ZNF676 T 0.47 0.07 2.00E-6 0.67 0.0097 0.702
rs4387287 10:105677897 OBFC1 A 0.08 0.12 2.00E-11 0.61 0.0022 0.934
Lee et al.23
rs10466239 10:43849827 FXYD4, RASGEF1A T 0.07 4.51d 7.00E-6 0.11 −0.0298 0.452
rs34596385 6:141926004 AK097143 T 0.05 −4.53d 6.00E-6 0.01 −0.0891 0.513
rs11787341 8:19102564 LOC100128993 A 0.06 4.91d 9.00E-7 0.07 0.0320 0.520
rs10904887 10:17188641 TRDMT1 T 0.47 4.61d 4.00E-6 0.81 −0.0130 0.697
rs16859140 3:111792594 TMPRSS7 C 0.28 4.58d 5.00E-6 0.11 −0.0151 0.697
rs73394838 22:30225973 ASCC2 G 0.06 4.44d 9.00E-6 0.27 0.00541 0.839
rs4902100 14:62549819 SYT16 G 0.28 4.64d 4.00E-6 0.23 −0.0011 0.968
rs7680468 4:108304199 DKK2, PAPSS1 T 0.03 −5.47d 5.00E-8 0.02 −0.0025 0.978
Saxena et al.24
rs2098713 5:37144574 C5orf42 T 0.47 −0.25 3.00E-6 0.76 −0.0543 0.058
rs74019828 16:58209274 CSNK2A2 A 0.16 −0.38 5.00E-8 0.05 −0.0074 0.899
Gu et al.25
rs6028466 20:38129002 DHX35 A NRe 0.192 3.00E-7 0.25 −0.0473 0.103
rs654128 6:117086378 KPNA5 T NRe 0.122 3.00E-6 0.09 −0.0588 0.151
rs621559 1:43645411 WDR65 A NRe 0.16 2.00E-6 0.32 −0.0344 0.196
rs398652 14:56525569 PELI2 A NRe 0.12 2.00E-6 0.35 −0.0115 0.647
Liu et al.26 rs17653722 12:52587518 KRT80 T NRe 0.122 7.00E-6 0.06 0.0085 0.871
Table 2. Adjusted analysis of log-transformed TL using 34 SNPs found in adult studies in healthy African 
American children and adolescents in SAGE: San Francisco Bay Area, 2006–2015. Regression adjusted for sex, 
age, genetic ancestry, maternal educational attainment, health insurance type and batch effects. aReported Effect 
Allele. bEffect Allele Frequency. cAdditive linear regression ß coefficient. dT-test test statistic reported instead of 
ß coefficient. eNR = Not Reported.
SNP Chr. Position Associated Gene EAa
Previously Reported SAGE (n = 492)
EAFb ßc (SE) P EAFb ßc (SE) P
rs594119 6:124940213 NKAIN2 T 0.19 −0.05 (0.01) 2.19E-5 0.15 −6.1E-2 (0.03) 0.055
rs11703393 22:44512124 PARVB G 0.27 −0.04 (0.01) 1.69E-4 0.43 −3.4E-2 (0.02) 0.166
rs2300383 21:35250086 ITSN1 G 0.47 −0.04 (0.01) 7.42E-6 0.73 2.2E-2 (0.03) 0.438
rs528983 4:115976690 NDST4 G 0.11 −0.07 (0.01) 7.88E-6 0.15 −2.1E-2 (0.03) 0.523
rs12678295 8:2748377 MYOM2, CSMD1 G 0.40 −0.04 (0.01) 1.92E-4 0.22 −4.7E-3 (0.03) 0.870
rs10496920 2:142996517 LRP1B, LOC100129955 G 0.18 0.05 (0.01) 4.60E-4 0.15 −4.4E-3 (0.03) 0.895
Table 3. Adjusted analysis of log-transformed TL using six SNP’s found in pediatric study healthy African 
American children and adolescents in SAGE: San Francisco Bay Area, 2006–2015. Regression adjusted for sex, 
age, genetic ancestry, maternal educational attainment, health insurance type and batch effects. aReported Effect 
Allele bEffect Allele Frequency. cAdditive linear regression ß coefficient.
www.nature.com/scientificreports/
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34 variants that have been used in recent years as proxies of TL in studies of disease risk17,27. We did not replicate 
these genetic associations in our study population of African American children and adolescents. Pediatric stud-
ies of TL by other groups29,30 have also been unable to replicate associations found among adults, suggesting that 
the genetic components influencing TL may differ between adult and pediatric populations. It is possible that 
variants identified in adults relate to telomere maintenance in adulthood but do not regulate TL during earlier 
developmental windows. For example, resistance to telomere shortening during childhood may be influenced by 
genetic factors impacting telomerase, a critical enzyme in telomere elongation41 that is influenced by genetic loci42 
and shows age-related reduction in activity43. TL is determined prior to adulthood dependent on the TL setting 
at birth and the rates of shortening and elongating during the first two decades of life10. These factors have genetic 
influences that have yet to be fully characterized1,10.
We attempted replication of six TL-associated genetic variants discovered in healthy children of European 
ancestry30. We found no significant association with TL among the six variants independently or in a weighted 
GPS, which tests cumulative variation at multiple genetic loci. Heritability estimates of TL range from 36% to 
82%11, yet has only been reported in populations of European ancestry and may not be generalizable to other pop-
ulations. Similarly, genetic determinants of TL have primarily been studied in populations of European or Asian 
descent. Recent studies attempting to replicate and/or identify genetic associations with TL in non-European 
populations, including Punjabi Sikh24, Han Chinese26,44 and Bangladeshi45, have had mixed success. Among the 
Figure 1. Adjusted association between log-transformed TL and GPS in healthy African American children 
and adolescents in SAGE: San Francisco Bay Area, 2006–2015. Regression association adjusted for sex, age, 
genetic ancestry, maternal educational attainment, health insurance type and batch effects.
Figure 2. Results of GWAS for TL in healthy African American children and adolescents in SAGE: San 
Francisco Bay Area, 2006–2015. (A) Manhattan plot of the GWAS of TL with three SNPs relevant to telomere 
biology highlighted. Genome-wide significance threshold is indicated as red line (P = 1.2 × 10−7) and suggestive 
significance threshold is indicated as blue line (P = 2.3 × 10−6). (B) Expansion of 1 Mb flanking region around 
the top hit (rs1483898) with surrounding SNPs colored by amount of linkage disequilibrium with the top SNP, 
indicated by pairwise r2 values from hg19/November 2014 1000 Genomes AFR.
www.nature.com/scientificreports/
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limited set of studies assessing TL-associated genetic variants in populations of African ancestry, all have been 
performed in adult populations. One study discovered genetic variants associated with TL in adults of European 
ancestry that were not associated in an adult population of African Americans22. Another study in adult African 
Americans was only able to replicate the effects of variants in TERC, the gene encoding the enzyme telomerase, 
that had been identified in populations of European ancestry46. We found a subtle positive association between 
the proportion of African ancestry and TL in African American children and adolescents, which is consistent 
with research among adults34. Considering TL dynamics vary by race/ethnicity32–34, our study augments the cur-
rent literature by demonstrating that TL-associated genetic variants differ between ancestral populations in the 
pediatric age range. Ancestry-specific genetic associations with a phenotypic trait have been demonstrated pre-
viously47, thus, the difference we observed may result from population-specific effects impacting genetic regu-
lation of TL. It is worth noting regional variation in environmental and social exposures between SAGE’s urban 
San Francisco Bay Area and the more rural Nancy, France of the Stathopoulou et al. study48 as potential factors 
effecting the association between genetic variants and TL and possibly precluding replication of the Stathopoulou 
et al. study.
We identified associations with TL in biologically relevant pathways relating to apoptosis, cell senescence and 
telomere replication. The most significant association, reaching genome-wide significance, was for rs1483898. 
Rs1483898 is located on the q21.1 arm of chromosome 14 in the regulatory region of LRFN5, a neuronal trans-
membrane protein. In our population of African American children and adolescents, increasing copies of the A 
allele of rs1483898 associated with longer TL. The A allele of rs1483898 has allele frequencies of 0.74, 0.86 and 
0.45 in the African, European and East Asian populations of 1000Genomes, respectively49.
We identified 41 variants that were suggestively associated with TL. The A allele of rs9675924, located within 
an intron of cell cycle regulator CABLES1 on chromosome 18, is associated with shorter TL in our study popula-
tion. CABLES1 is co-expressed with protein kinase CDK5, a known contributor to apoptosis in certain neuronal 
diseases39. CABLES1 has also been shown to inhibit cell proliferation and induce cell senescence in umbilical 
endothelial cells40. The C allele of rs4305653 associated with longer telomeres. This variant is located on chromo-
some 5 within an intron of TTC37, a component of the SKI complex which mediates protein-protein interactions. 
TTC37 is co-expressed with apoptosis-promoting protein APAF1 as well as with TEP1, a protein that binds to the 
RNA subunit of telomerase. There is evidence that TEP1 is involved in telomere replication but the nature of that 
relationship in humans remains unclear39. Ultimately, co-expression is only a proxy for co-regulation50; replica-
tion and further investigation of our results are needed to better characterize relevant associations between these 
genetic loci and telomere biology.
Our study lacked an independent replication cohort to assess the reproducibility of our genetic associations 
due to the unique characteristics of our study population (African American children and adolescents with 
genetic and TL data). Measurement of TL in our study population provided a snapshot of TL at a specific point 
in the life course. Longitudinal studies of TL are required to understand changes in TL over the life course. The 
major advantages of our study are that (1) it provides novel information about the genetic determinants of TL in 
a non-European pediatric population, and (2) our depth of phenotype data allowed us to adjust for social, envi-
ronmental and genetic covariates (Supplementary Table S1).
It is important to note that while our study was well powered to detect moderate to strong effects (f2 = 0.15 
and 0.35, respectively) in common variants with a MAF of 0.05 or higher in our study population, we were not 
powered to detect weak effects (f2 < 0.02)51. It is possible that our inability to replicate the reported variants may 
be explained by limited statistical power; however, this would only be the case if these variants had effect sizes in 
our population that were significantly lower than the strong effects reported in previous studies. All but two of 
the variants of the 40 variants we attempted to replicate were common (MAF > 0.05) in both the populations in 
which they were discovered and in our study population.
Figure 3. Comparison of mean TL between rs1483898 genotypes in healthy African American children and 
adolescents in SAGE: San Francisco Bay Area, 2006–2015.
www.nature.com/scientificreports/
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In summary, the paucity of research on factors affecting TL in pediatric and non-European populations cre-
ates a knowledge gap in the scientific understanding of gene-environment interactions regulating telomeres. 
Epidemiological studies reporting associations between TL and disease risk are potentially biased by the disease 
itself or exposures relating to treatment. Genetic proxies for TL have recently been employed to overcome these 
and other potential biases, such as social and environmental exposures. A critical assumption when using genetic 
proxies for TL is that they are generalizable across age and racial/ethnic groups. However, we were unable to 
replicate previous findings of TL-associated variants in our study population. We also identified novel genetic 
associations with TL that have not been identified in previous studies in pediatric or adult populations. Further 
telomere research in pediatric populations from diverse ancestral backgrounds is required to fully understand the 
impacts of age- and population-effects on the genetic regulation of TL.
Methods
Ethics statement. This study has been approved by the institutional review boards of University of 
California San Francisco, Kaiser Permanente and Children’s Hospital Oakland. Written informed consent was 
obtained from all subjects or from their appropriate surrogates for participants under 18 years old. All methods 
were performed in accordance with the relevant guidelines and regulations for human subject research.
Study population. Our study included 492 healthy controls from the Study of African Americans, Asthma, 
Genes and Environments (SAGE). SAGE is one of the largest ongoing gene-environment interaction studies of 
asthma in African American children and adolescents in the USA. SAGE includes detailed clinical, social, and 
environmental data on asthma and asthma-related conditions. Full details of the SAGE study protocols have been 
described in detail elsewhere52–54. Briefly, SAGE was initiated in 2006 and recruited participants with and without 
asthma through a combination of clinic- and community-based recruitment centers in the San Francisco Bay 
Area. Recruitment for SAGE ended in 2015. All participants in SAGE self-identified as African American and 
self-reported that all four grandparents were African American.
After all quality control procedures relating to TL measurement, TL was computed for 596 healthy controls in 
SAGE from whole blood. There were 495 healthy controls with complete sex, age, African ancestry, maternal edu-
cational attainment and health insurance information. Three individuals showed extreme outlier measurements 
for TL (three times the interquartile range) and were thus removed.
Covariates. Maternal educational attainment and health insurance type were used as proxies of SES55–57. 
Maternal educational attainment was dichotomized based on whether a participant’s mother had pursued educa-
tion beyond high school (i.e., ≤12 versus >12 years of education). Health insurance type was defined as private 
versus public insurance. The genetic ancestry of each participant was determined using the ADMIXTURE soft-
ware package58 with the supervised learning mode assuming two ancestral populations (African and European) 
using HapMap Phase III data from the YRI and CEU populations as references59.
Variant selection and genotyping. TL-associated variants were selected for replication using criteria set 
a priori. We only tested genetic associations if the (i) published association reaches genome-wide significance 
(P ≤ 5 × 10−8) on NHGRI-EBI GWAS Catalog by October 26, 2017; (ii) variant used as genetic proxy of TL in at 
least one study; (iii) variant reaches suggestive genome-wide significance (P ≤ 5 × 10−5) in a novel GWAS of TL 
in children; (iv) variant has a minor allele frequency (MAF) of at least 1% in our study population. We identified 
variants from 11 studies17–26,30. Ten of the 11 studies were performed in adult populations and nine of the 11 stud-
ies were performed in populations of European descent, with the remaining two performed in Punjab Sikh24 and 
Han Chinese26 populations. In total, we identified 40 variants from the literature, of which 12 were genotyped and 
28 were imputed. The 28 imputed SNPs had r2 (squared correlation between imputed and expected genotypes) 
ranging from 0.88 to 1.00.
DNA was isolated from whole blood collected from SAGE participants at the time of study enrollment using 
the Wizard® Genomic DNA Purification kits (Promega, Fitchburg, WI). Samples were genotyped with the 
Affymetrix Axiom® LAT1 array (World Array 4, Affymetrix, Santa Clara, CA), which covers 817,810 SNPs. This 
array was optimized to capture genetic variation in African-descent populations such as African Americans and 
Latinos60. Genotype call accuracy and Axiom array-specific quality control metrics were assessed and applied 
according to the protocol described in further detail in Online Resource 1. Data was submitted to the Michigan 
Imputation Server and phased using EAGLE v2.3 and imputed from the Haplotype Reference Consortium r1.1 
reference panel using Minimac361. Imputed SNPs were included if they had an r2 higher than 0.3. Quality con-
trol inclusion criteria consisted of individual genotyping efficiency >95%, Hardy-Weinberg Equilibrium (HWE) 
P > 10−4, and MAF > 5%. Cryptic relatedness was also assessed to ensure that samples were effectively unrelated. 
Samples with an estimate of genetic relatedness greater than 0.025 were excluded. After quality control proce-
dures, 7,519,176 imputed and genotyped SNPs were available for analysis.
Telomere length measurement. DNA isolation and quantification. Genomic DNA was isolated from 
whole blood according to manufacturer’s recommendation using Wizard® Genomic DNA Purification Kits 
(Promega, Fitchburg, WI). A NanoDrop® ND-1000 spectrophotometer (Thermo Scientific) was used to assess 
DNA quality and quantity. All samples assayed had absorbance ratios (260/280) between 1.8 and 2.0.
Determination of Relative Telomere Length. Relative TL for each sample was determined using the quantitative 
real time PCR (qPCR) method first described by Cawthon et al., which quantified TL in terms of telomere/single 
copy gene (T/S) expression ratios62. This protocol was modified with regard to data processing and control sam-
ples as previously published by O’Callaghan et al. and described in further detail in Supplemental Methods63. In 
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brief, relative TL for each sample was calculated using the delta-delta CT (2−∆∆Ct) formula62. Using this formula, 
the TL computed for each SAGE sample is proportional to the T/S ratio of that sample normalized to the T/S ratio 
of the PCR plate positive DNA control sample62,64,65. Inter- and intra-experimental coefficients of variation for 
our internal control (1301 cell line DNA) were 3% and 4.25%, respectively. Average amplification efficiency across 
plates was ≥90% for telomere and 36B4 assays. As TL was not normally distributed in our study population, we 
performed all parametric tests on a log-transformation of TL.
Replication analysis. Genotypes for all 40 previously published SNP’s in adults and children were tested 
for association with log-transformed TL in a multivariable linear regression analysis. Regression analyses were 
run separately for each SNP under an additive model to calculate the individual effect of the SNP on TL. Each 
regression analysis was adjusted for biological, environmental and social factors that may impact TL including 
sex, age, African ancestry, maternal education, and health insurance type. We adjusted for qPCR plate ID in all 
regression analyses to ensure that our results were not impacted by qPCR batch effects. To ensure direct compar-
ison of results between previous studies and our current study we coded the effect alleles in our analysis to be the 
same as those used in previous studies.
Genetic Prediction Score construction. Recent research suggests the cumulative effect of multiple 
genetic markers may be a stronger predictor of a quantitative phenotype than the individual markers66,67. We 
therefore constructed a weighted GPS based on the six variants from Stathopoulou et al. to test their cumulative 
effect on TL30. We calculated each subject’s weighted GPS by summing the number of alleles (0, 1 or 2) associ-
ated with longer telomeres after weighting the allele count by the reported β-coefficient from the literature. We 
assumed that an effect allele having a positive β-coefficient meant that each additional copy of that allele was 
positively associated with TL. We used the GPS as a predictor in a linear regression against log-transformed 
TL controlling for sex, age, genetic ancestry, maternal educational attainment, health insurance type and batch 
effects. We were unable to calculate a weighted GPS based on the 34 variants in adult studies because the effect 
size could not be standardized across the studies.
Calculation of population-specific genome-wide significance threshold. The standard GWAS 
threshold for statistical significance is 5 × 10−8. This number was derived by applying a Bonferroni correction for 
multiple testing to a dataset of one million independent markers/SNPs. However, in many cases, this threshold 
is overly conservative and can be inappropriate when (1) a smaller number of markers is genotyped, and (2) the 
assumption of independence of tests is violated.
In order to adjust the Bonferroni correction based on the actual number of independent test performed on 
our dataset, we determined the number of independent tests using the protocol published by Sobota et al.68. This 
method estimates the effective number of independent tests in a genetic dataset after accounting for linkage 
disequilibrium (LD) between SNPs using the LD pruning function in the PLINK 1.9 software package69. The fol-
lowing parameters were used in PLINK 1.9 as advised by the authors: 100 SNP sliding window, step size of 5 base 
pairs, and a variance inflation factor of 1.25. Applying this method on 7,519,176 genotyped and imputed SNPs 
yielded 431,896 independent tests, which was then used to calculate the genome-wide significance threshold 
(Bonferroni correction 0.05/431,896 = 1.2 × 10−7). A suggestive threshold was set at 2.3 × 10−6 for association 
results based on the widely used formula: 1/(effective number of tests)70.
Discovery Genome-Wide Association Study. We performed a genome-wide association study 
(GWAS) using 7,519,176 genotyped and imputed SNPs to assess the relationship between SNP genotype and 
log-transformed TL. The GWAS linear regression model adjusted for sex, age, African ancestry, maternal edu-
cational attainment, health insurance type and batch effects. All testing was performed using PLINK1.969. 
Manhattan plots (Fig. 2A,B) were generated using the qqman package71 in the R statistical software environment 
(R Development Core Team 2010) and LocusZoom72. Curated protein-protein interactions were extracted using 
the STRING database39. An integrated confidence score for the interaction ranges from 0.5 (medium confidence) 
to 1 (high confidence).
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